5-Chlorosalicylic Acid → HCID 10068311, 화합물

HRID 421027

반응식

HRID 421027 반응식
[Cl:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[CH2:12]([O:14][C:15]([C:17]1[C:18]2[CH2:26][CH2:25][CH2:24][CH2:23][C:19]=2[S:20][C:21]=1[NH2:22])=[O:16])[CH3:13]>>[CH2:12]([O:14][C:15]([C:17]1[C:18]2[CH2:26][CH2:25][CH2:24][CH2:23][C:19]=2[S:20][C:21]=1[NH:22][C:7](=[O:9])[C:6]1[CH:10]=[C:2]([Cl:1])[CH:3]=[CH:4][C:5]=1[OH:11])=[O:16])[CH3:13]

참가 물질

3

반응물 2

HCID 94475-Chlorosalicylic AcidHCID 78262Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

생성물 1

HCID 10068311HCID 10068311, 화합물수율 49.6%

실험 절차

Using 5-chlorosalicylic acid and 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ethyl ester as the raw materials, the same operation as the example 16 gave the title compound.

출처 및 근거

ORD 기록
ord-6fc37020a02a42d1969ea4ec412bb822
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08097759B2

연결된 노트

불러오는 중…